Chemical formula: C₇H₁₆N₄O₄S₂ Molecular mass: 284.35 g/mol PubChem compound: 29566
Taurolidine has shown no evidence of teratogenicity in animal studies, but administration to pregnant women should only be undertaken if the clinician considers it essential.
Taurolidine has shown no evidence of teratogenicity in animal studies, but administration to lactating women should only be undertaken if the clinician considers it essential.
None stated.
Taurolidine is generally well-tolerated. Occasional local pain or irritation may occur in conscious, sensitive patient following the initial instillation, and can be abolished for subsequent taurolidine instillations by the pre-installation of 10 ml 0.1% lignocaine.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
